Tokio Marine Capital has appointed Citigroup to advise on the sale of Showa Yakuhin Kako Co., Reuters reports. Japanese funds and strategic buyers are among potential bidders for the generic drug company.

In 2008, the Japanese private equity firm led a consortium to acquire the asset from Jafco Co. for about $400 million including debt. The consortium included Polaris Capital Group and PineBridge Investments, formerly AIG Japan.

Click here for the story from Reuters.